Article published on JPIAMR website, June 2022
The Coordination and Support Action (CSA) DESIGN OH AMR will lay the foundation of the candidate OH AMR partnership.
The Coordination and Support Action (CSA) DESIGN One Health AntiMicrobial Resistance (DESIGN OH AMR) has been created in response to the HORIZON-HLTH-2021-DISEASE-04-05 call: “A roadmap towards the creation of the European partnership on One Health antimicrobial resistance (OH AMR).”
DESIGN OH AMR aims to coordinate a One Health response to link key actors of the siloed AMR research and innovation landscape. The DESIGN OH AMR action will operate within the framework of the European One Health Action Plan against AMR to support an interdisciplinary approach to overcome fragmentation and bring diverse stakeholders together in the candidate European co-funded partnership on OH AMR. The action will thus focus on activities that contribute to destination 3 of the European Commission Health Programme in Horizon Europe “Tackling diseases and reducing disease burden.”
This CSA will develop the strategic basis for the candidate European co-funded partnership on OH AMR through engaging with, and building on, networks of research funders, policy makers, relevant agencies, European partnerships under the Horizon 2020 Framework Programme, and authorities to strengthen coordination and collaboration among different fields of research and innovation with relevance to AMR.
DESIGN OH AMR will lay the foundation of the candidate OH AMR partnership.
Read more about the candidate OH AMR Partnership.
Read more about the consultations regarding the OH AMR Partnership future SRIA.
Name: DESIGN One Health AntiMicrobial Resistance (DESIGN OH AMR)
Coordinator: Swedish Research Council (SRC)
Partners: Agence Nationale de la Recherche (ANR), Zorgonderzoek Nederland ZON (ZonMw), Ministry of Health Israel (CSO-MOH), Deutsches Zentrum für LUFT und Raumfahrt e. V. (DLR), Ministero della Salute (IT-MOH), Lietuvos Mokslo Taryba (LMT), Instituto de Salud Carlos III (ISCIII), International Centre for Antimicrobial Resistance Solutions (ICARS), Fondazione Penta (PENTA), European Public Health Alliance (EPHA)
Associated Partners: Knowledge Transfer Limited (KTN), United Kingdom Research and Innovation (UKRI)
Duration: May 2022 – May 2024
- WP1. Coordination and OH AMR partnership proposal and governance development, leading agency SRC.
- WP2. SRIA development and research prioritisation, leading agency ANR.
- WP3. Global AMR research collaboration, leading agency SRC.
- WP4. Communication and engagement, leading agency SRC.